MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism

Chenwei Pan; Xiaodong Wang; Keqing Shi; Yi Zheng; Jie Li; Yongping Chen; Lingxiang Jin; Zhenzhen Pan

doi:10.1371/journal.pone.0152090

Loading metrics

Open Access

Peer-reviewed

Research Article

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism

Chenwei Pan ,

Contributed equally to this work with: Chenwei Pan, Xiaodong Wang

Affiliation Department of Infectious Disease, The Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China
⨯
Xiaodong Wang ,

Contributed equally to this work with: Chenwei Pan, Xiaodong Wang

Affiliation Department of Infectious Disease, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
⨯
Keqing Shi,

Affiliation Department of Infectious Disease, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
⨯
Yi Zheng,

Affiliation Department of Infectious Disease, The Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China
⨯
Jie Li,

Affiliation Department of Infectious Disease, The Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China
⨯
Yongping Chen,

Affiliation Department of Infectious Disease, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
⨯
Lingxiang Jin ,

* E-mail: wzzhenzhenpan@126.com (ZP); future1006@sina.com (LJ)

Affiliation Department of Infectious Disease, The Second Affiliated Hospital & Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou, China
⨯
Zhenzhen Pan

* E-mail: wzzhenzhenpan@126.com (ZP); future1006@sina.com (LJ)

Affiliation Department of Infectious Disease, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
⨯

MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells through Regulating the Tumor Metabolism

Chenwei Pan,
Xiaodong Wang,
Keqing Shi,
Yi Zheng,
Jie Li,
Yongping Chen,
Lingxiang Jin,
Zhenzhen Pan

Published: May 3, 2016
https://doi.org/10.1371/journal.pone.0152090

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Hyperexpression techniques
Is the Subject Area "Hyperexpression techniques" applicable to this article?

Thanks for your feedback.
Luciferase
Is the Subject Area "Luciferase" applicable to this article?

Thanks for your feedback.
Cell viability testing
Is the Subject Area "Cell viability testing" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.